Trials / Active Not Recruiting
Active Not RecruitingNCT06853990
Innovative Automated Insulin Delivery System for Type 2 Diabetes
A Single-arm Trial With an Innovative Automated Insulin Delivery System for Type 2 Diabetes ("Twiist-T2D")
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- Deka Research and Development · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to learn if the twiist insulin delivery system works to treat adults with insulin-treated type 2 diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | twiist insulin delivery system | twiist system includes a novel insulin pump, a CGM sensor and the DEKA Loop algorithm |
Timeline
- Start date
- 2025-04-14
- Primary completion
- 2026-04-01
- Completion
- 2026-06-01
- First posted
- 2025-03-03
- Last updated
- 2026-01-05
Locations
30 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06853990. Inclusion in this directory is not an endorsement.